Praxis Precision Medicines (PRAX) Preferred Dividend Payments (2019 - 2020)
Praxis Precision Medicines (PRAX) recorded quarterly Preferred Dividend Payments of $950000.0 in Q4 2020, down 75.91% quarter-over-quarter from $3.9 million in Q3 2020, and down 44.77% on a YoY basis from $1.7 million in Q1 2020.
Praxis Precision Medicines (PRAX) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Praxis Precision Medicines' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $950000.0 for Q4 2020.
- In Q4 2020, Preferred Dividend Payments fell 44.77% year-over-year to $950000.0; the TTM figure through Sep 2021 stood at $950000.0 (down 90.27% YoY), while the FY2020 annual figure was $9.0 million, up 74.0% from the prior year.
- Preferred Dividend Payments was $950000.0 for Q4 2020 at Praxis Precision Medicines, down from $3.9 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $3.9 million in Q3 2020 to a low of $950000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Praxis Precision Medicines | 200.22 Mn | -586.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 950,000.00 |
| Sep 30, 2020 | 3.94 Mn |
| Jun 30, 2020 | 2.04 Mn |
| Mar 31, 2020 | 2.06 Mn |
| Dec 31, 2019 | 1.72 Mn |
| Sep 30, 2019 | 1.27 Mn |